ATE433111T1 - Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren - Google Patents

Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren

Info

Publication number
ATE433111T1
ATE433111T1 AT05797071T AT05797071T ATE433111T1 AT E433111 T1 ATE433111 T1 AT E433111T1 AT 05797071 T AT05797071 T AT 05797071T AT 05797071 T AT05797071 T AT 05797071T AT E433111 T1 ATE433111 T1 AT E433111T1
Authority
AT
Austria
Prior art keywords
invasiveness
aggressiveness
marker
vimentin
invasivity
Prior art date
Application number
AT05797071T
Other languages
English (en)
Inventor
Ali Bouamrani
Emmanuel Gay
Jean-Paul Issartel
Francois Berger
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE433111T1 publication Critical patent/ATE433111T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05797071T 2004-09-17 2005-09-15 Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren ATE433111T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409857A FR2875601B1 (fr) 2004-09-17 2004-09-17 Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs
PCT/EP2005/054598 WO2006030023A1 (fr) 2004-09-17 2005-09-15 Vimentine phosphorylée comme marqueur de l'agressivité et/ou l'invasivité des tumeurs

Publications (1)

Publication Number Publication Date
ATE433111T1 true ATE433111T1 (de) 2009-06-15

Family

ID=34953933

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05797071T ATE433111T1 (de) 2004-09-17 2005-09-15 Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren

Country Status (7)

Country Link
US (1) US20070265185A1 (de)
EP (1) EP1789802B1 (de)
AT (1) ATE433111T1 (de)
DE (1) DE602005014789D1 (de)
ES (1) ES2326987T3 (de)
FR (1) FR2875601B1 (de)
WO (1) WO2006030023A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006292278B2 (en) * 2005-09-20 2012-03-08 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US8377636B2 (en) * 2007-04-13 2013-02-19 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to kinase inhibitors
AU2008307634A1 (en) * 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US8048621B2 (en) * 2007-10-03 2011-11-01 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
US20110171124A1 (en) * 2009-02-26 2011-07-14 Osi Pharmaceuticals, Inc. In situ methods for monitoring the EMT status of tumor cells in vivo
AU2011223655A1 (en) * 2010-03-03 2012-06-28 OSI Pharmaceuticals, LLC Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
JP2014519813A (ja) 2011-04-25 2014-08-21 オーエスアイ・ファーマシューティカルズ，エルエルシー 癌薬剤発見、診断、および治療におけるｅｍｔ遺伝子シグネチャーの使用
WO2013151314A1 (ko) * 2012-04-03 2013-10-10 연세대학교 산학협력단 비멘틴을 포함하는 탈모 억제 또는 발모 촉진용 조성물
JP2016512197A (ja) * 2013-03-05 2016-04-25 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 間葉及び上皮間葉形質転換循環腫瘍細胞のための特異的検出ツール
US20170307615A1 (en) * 2014-09-24 2017-10-26 Geisinger Health System Immunohistochemistry Quality Management Program Using Cultured Cell Lines for Tissue Microarray (TMA) Blocks
WO2017100789A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. Srm/mrm assays
CN113564172A (zh) * 2021-06-30 2021-10-29 优葆优保健康科技(宁波)有限公司 一种液体活检肿瘤细胞dna适配体
CN116298288A (zh) * 2023-01-10 2023-06-23 复旦大学附属肿瘤医院 Abcg1磷酸化位点作为肿瘤生物标记物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3829226B2 (ja) * 1999-07-07 2006-10-04 独立行政法人理化学研究所 ビメンチンの切断産物に対する抗体
US7910314B2 (en) * 2002-03-01 2011-03-22 Roger Williams Hospital Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
WO2003076651A2 (en) * 2002-03-14 2003-09-18 Qlt Inc. Cancer associated araf1 protein kinase and its uses

Also Published As

Publication number Publication date
ES2326987T3 (es) 2009-10-22
FR2875601A1 (fr) 2006-03-24
DE602005014789D1 (de) 2009-07-16
EP1789802A1 (de) 2007-05-30
EP1789802B1 (de) 2009-06-03
WO2006030023A1 (fr) 2006-03-23
US20070265185A1 (en) 2007-11-15
FR2875601B1 (fr) 2007-04-13

Similar Documents

Publication Publication Date Title
DE602005014789D1 (de) Phosphorylierte vimentin als marker für die aggressivität und /oder invasivität von tumoren
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
WO2003021227A3 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
WO2004031411A3 (en) Genes and polypeptides relating to human pancreatic cancers
EA200800278A1 (ru) АНТИ-αβ-АНТИТЕЛА И ИХ ПРИМЕНЕНИЕ
MX2009010439A (es) Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2012154567A3 (en) Human invasion signature for prognosis of metastatic risk
WO2004056874A3 (en) Neuropilin-1 inhibitors
CR9100A (es) Metodos y sistemas para el pronostico y tratamiento de tumores solidos
ATE346301T1 (de) Diagnose von krebsstadium oder aggressivität
WO2004031231A3 (en) Genes and polypeptides relating to prostate cancers
ATE531388T1 (de) Verwendung von anti-alpha5beta1-antikörpern zur hemmung der krebszellproliferation
DE60016548D1 (de) Snail, neuer marker für die entwicklung von tumoren und zielprotein neuer antitumoraler verbindungen
EP1377596A4 (de) Ttk in der diagnose und als therapeutisches target bei krebs
DE50311312D1 (de) Verfahren zum untersuchen von körperflüssikeiten auf krebszellen sowie entsprechende analysekits
TW200626900A (en) Wnt proteins and detection and treatment of cancer
EP2366712A3 (de) TS10Q23.3 Tumorunterdrückung
WO2006095086A3 (fr) Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence.
WO2005113831A3 (en) Biomarkers for multiple sclerosis and methods of use thereof
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
WO2005024067A3 (en) Genetic analysis for stratification of breast cancer risk
WO2003073821A3 (en) Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
WO2004003166A3 (en) Antibodies and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties